The 2024 BioStock Life Science Summit: Watch the Highlights Now!
On November 20–21, we hosted the seventh annual BioStock Life Science Summit, and the entire is now available to watch online! Over the course of two days, more than 30 life science companies presented their pipelines and investment cases to both investors and potential partners. The event also featured thought-provoking panel discussions and eye-opening keynotes featuring some of the most influential voices in the industry.
The BioStock Life Science Summit is the Nordic region’s leading forum for early-stage and growth-phase life science companies. The event bridges innovation and capital by providing a platform for sector companies to meet both Swedish and international investors and potential partners in a welcoming and collaborative environment.
This year’s Summit saw key industry leaders, both from Sweden and abroad, engage in high-level dialogues and forge valuable connections – both on and off stage.
If you missed the event or want to revisit a particular session, you can now watch the full program from the BioStock Life Science Summit 2024 below!
Panels
What’s the Big Deal? – Anu Balendran, Novo Nordisk; Ton Berkien, Cantargia; Tara Heitner, formerly Ferring Pharmaceuticals; Sarah Fredriksson, Aqilion.
Medtech – a hidden gem? – Karin Leire, Segulah Medical Acceleration; Magnus Holm, Peppermint Venture Partners; Hanna Sjöström, Neola Medical & SwedenBio; Fiona Law, Potter Clarkson; Moderator: Carl Borrebaeck
Show us the Money! – Shamim Dadvar, HealthCap; Markus Dietrich, Hadean Ventures; Farzad Abdi-Dezfuli, Sarsia Management; Christer Fåhraeus, FSG Fund; Jacob Lange Moresco, Sunstone Life Science Ventures
Global trends in healthcare – Andreas Dirnagl, DNB Bank New York; Claus Henrik Johansen, Global Health Invest
Keynotes
Unlocking the Greater China Market: Strategic Pathways for Nordic Medical Innovations – William Pay, Chief Investment & Strategy Advisor to the Chairman at HK WinHealth Pharma Group
Investment insights: Challenges & Opportunities in Global Healthcare – Claus Henrik Johansen, Founder and CEO of Global Health Invest
How the US election will impact the future of life science – Andreas Dirnagl, Senior Advisor Healthcare at DNB Bank New York
Live interview
Public Markets – A brief Outlook with Nasdaq – Carsten Borring, Head of Listings & Capital Markets at NASDAQ Copenhagen
Company presentations
Schedule
November 20
08:00 Registration & Breakfast
09:00 Opening & Nasdaq Bell Ringing Carsten Borring – Nasdaq Jonas Söderström – BioStock Peter Legind-Hansen – Nasdaq
09:05 Panel: What’s the Big Deal? Moderated by BioStock’s CEO Jonas Söderström Anu Balendran – Novo Nordisk Sarah Fredriksson – Aqilion Tara Heitner – formerly Ferring Pharmaceuticals Ton Berkien – Cantargia
09:35 Cereno Scientific – Sten R. Sörensen, CEO
09:50 Medivir – Jens Lindberg, CEO
10:05 Colzyx – Jens Hansson, Chair
10:20 Coffee Break
10:50 Zerion Pharma – Ole Wiborg, CEO
11:05 Oxcia – Ulrika Warpman Berglund, CEO
11:20 Herantis Pharma – Antti Vuolanto, CEO
11:35 Unlocking the Greater China Market – Strategic Pathways for Nordic Medical Innovations William Pay – HK WinHealth Pharma Group
12:00 Lunch
13:00 Oncopeptides – Sofia Heigis, CEO
13:15 Initiator Pharma – Claus Olesen, CEO
13:30 Hamlet BioPharma – Catharina Svanborg, Chair
13:45 Njord Medtech – Jacob Ahrnstein, CEO
13:50 Infonomy – Helmuth Kristen, CEO
13:55 Navari Surgical – Madeleine Gustavsson, CEO
14:00 Coffee Break
14:30 Elicera Therapeutics – Jamal El-Mosleh, CEO
14:45 IRLAB Therapeutics – Kristina Torfgård, CEO
15:00 Investments insights: Challenges & Opportunities in Global Healthcare Claus Henrik Johansen – Global Health Invest 15:30 Coffee Break
16:00 Lumito – Sanna Wallenborg, CEO
16:15 Simsen Diagnostics – Pontus Rehn, CEO
16:30 Panel: Medtech – a hidden gem? Moderated by Carl Borrebaeck, Chair of Paindrainer Fiona Law – Potter Clarkson Hanna Sjöström – Neola Medical Karin Leire – Segulah Medical Acceleration Magnus Holm – Peppermint Venture Partners
17:00 Closing Remarks
17:15 Shuttle busses to Executive Dinner venue [Invite Only]
November 21
08:00 Registration & Breakfast
09:00 Opening
09:05 Panel: Show us the Money! Moderated by BioStock’s CEO Jonas Söderström
Christer Fåhraeus – FSG Fund
Farzad Abdi-Dezfuli – Sarsia Management
Jacob Lange Moresco – Sunstone Life Science ventures
Markus Dietrich – Hadean Ventures
Shamim Dadvar – HealthCap
09:50 Lipum – Ola Sandborgh, CEO
10:05 PharmNovo – Bengt von Mentzer, Founder
10:20 Coffee Break
10:50 ExpreS2ion Biotech – Bent U. Frandsen, CEO
11:05 Cellevate – Laura Chirica, CEO
11:20 Annexin Pharmaceuticals – Anders Haegerstrand, CEO
11:35 How the US election will impact the future of life science
Andreas Dirnagl – DNB Bank
12:00 Lunch
13:00 SenzaGen – Peter Nählstedt, CEO
13:15 Ziccum – Ann Gidner, CEO
13:30 Sprint Bioscience – Martin Andersson, CSO
13:45 Aqilion – Sarah Fredriksson, CEO
14:00 Vesper Bio – Lovisa Sunesson, Director of Business Development
14:05 Curasight – Andreas Kjær, CSO
14:10 Abarceo Pharma – Adam Bruce, Chair
14:15 Coffee Break
14:55 Live interview: Public Markets – A brief Outlook with Nasdaq
Carsten Borring – Nasdaq Copenhagen
15:10 Abliva – Magnus Hansson, CMO
15:25 Cantargia – Göran Forsberg, CEO
15:40 Panel: Global trends in healthcare Moderated by BioStock’s CEO Jonas Söderström
Andreas Dirnagl – DNB Bank
Claus Henrik Johansen – Global Health Invest
16:10 Closing Remarks
16:15 After Work
EVENT PARTNERS
With more than 90 pct. of all US biotech, pharma & life science companies listed on Nasdaq, we know how to match savvy investors with trail-blazing inventors.
We are here to support your ideas and the next steps to a public offering that keeps you in control while raising capital to ignite your ambition. By the way, if you want to keep your ambition closer to home, Nasdaq in the Nordic is the leading hub for listed biotech and health care companies in Europe, with strong support from investors and innovation communities across the region.
How to join the Nasdaq family? – Read more here
Potter Clarkson is one of Europe’s leading full-service IP law firms.
Our sole objective is to help innovators and investors maximise the value of their business or investments by identifying, protecting, exploiting, and enforcing the required IP rights anywhere in the world.
With regards to biotechnology and the life sciences, our team is one of Europe’s largest. We are fiercely proud of our reputation as the European IP firm of choice for clients of all sizes, from ambitious start-ups and SMEs through to Big Pharma.
Having worked alongside investors in the Nordics, Germany, and the UK for decades we also know to deliver the comprehensive and commercial view of the IP in an investment required to support the best investment decisions.
The Aixial Group is an International Contract Research Organization (CRO), a member of the ALTEN Group, providing services in phase I-IV clinical trials and non-interventional studies. The CRO occupies a unique position in the clinical research industry, supporting biotech across all phases, as an expert in the operational delivery of clinical trials.
Our vision is to conduct clinical trials better than anyone else to help patients and ultimately save lives. We have earned a strong reputation for successfully delivering complex, demanding and innovative clinical trials, with specialist therapeutic expertise in oncology, cell & gene therapy and rare diseases.
Accountor is one of Northern Europe’s largest full-service agencies in the financial services industry. You find us in 18 cities in Sweden and in The Spark building, Medicon Village.
Accountor has specialist competence in assisting Life Science and Biotech companies with payroll management, accounting, and tax advisory services. Offering solutions based on need and can provide a comprehensive solution with payroll administration, accounting, qualified accounting and tax advice.
We can be involved throughout the company’s development and support during various changes, from start and changes in requirements of the financial reporting.
Read more how companies benefit from Accountor’s services here
Bondi Executive Search
Recruitment & Interim
Fluent in finding Leaders and Specialists in Life Science
Partner of Kestria, the world´s largest executive search alliance.
90+ cities | 40+ countries | 6 continents
Nordic Issuing – Your Partner in Nordic Financial Transactions
At Nordic Issuing, we offer a comprehensive range of issuance services, specializing in everything from IPOs to rights issues and directed share issues. We work closely with leading legal and financial advisors to ensure expertise in every transaction and market.
Our commitment to quality and client security is at the heart of everything we do. As your partner, we guarantee that each step of your financial journey is managed with care and professionalism.
Let Nordic Issuing guide you through the entire process!
Foyen is a nationwide law firm with profound understanding of the needs and conditions of growth companies.
Today, Foyen assists thousands of companies in various areas, ranging from business law, commercial agreements, corporate law, disputes, etc.
In 2024, Market & Corporate Law (MCL) was integrated into Foyen as part of Foyen’s initiative to become the leading law firm in stock market law and transactions. Many growth companies have now chosen Foyen as legal partner assisting boards and management, capital raises, acquisitions, reverse takeover, incentive programs and similar matters.
Ensure your legal security in a smooth and efficient manner with Foyen!
The DNB // Back Bay Partnership strengthens companies with financial and strategic guidance on growth opportunities across sector and development stage. We are a committed partner throughout the development journey, addressing positioning, partnering, financing, M&A strategies, and listing support and execution on U.S. and Nordic exchanges.
Great and exciting ideas arise when people meet. We believe in bringing together individuals and organisations with similar values and objectives. This is why we founded Haeger & Carlsson back in 1997.
We create the conditions required for individuals to become successful, and in such way contribute to the company’s success.
With a transparent and well-defined process and an industry leading network, we proud ourselves of being one of the leading recruitment companies in life science in the Nordic region.
Your Global CRO Partner in Clinical Research: TFS HealthScience is a global contract research organization that partners with biotech and pharmaceutical companies throughout their entire clinical development journey. With industry-leading expertise in key therapeutic areas and demand-driven strategic resourcing, TFS will meet the needs and strive to exceed the expectations of our partners and sponsors. Our experts are passionate about their disciplines, continually learning, enhancing and dedicating themselves to the success of your trial.
PRESENTING COMPANIES
Lund – A city full of possibilities
Among cobblestones and half-timbered houses, the medieval city of Lund is merged with modern buildings and innovative environments. The ties to the University are plentiful and the large number of students add their touch to the city.
The beautiful city of Lund is in the heart of the Öresund Region. Pulsating with history and culture, Lund offers a wealth of attractions for international visitors. Enjoy a range of experiences from restaurants, shopping, museums, entertainment and several hotels; all within walking distance. Famous for its University, Lund’s 40,000 students help create a vibrant and multicultural environment. The architecturally striking city centre has plenty of meeting places and green areas including the beautiful Botanical Gardens, the City Park and “Lundagård” park. The famous cathedral, ”Domkyrkan”, has fascinated visitors since the 12th Century and is the most popular attraction in southern Sweden with its 700,000 visitors each year.
History meets the future
Founded in the 11th Century, Lund is one of Sweden‘s oldest towns. Today, history and tradition meet innovation and the future. Renowned for its visionary thinking, Lund established one of the region’s first coin factories and the oldest Nordic school, ”Katedralskolan” in 1085. The Cathedral was built in the 12th Century and Lund University opened as Sweden‘s second institute of higher learning in 1666.
The mix of Middle Age and modern architecture is home to high-tech industry and a large graduate population. Inventions such as Bluetooth, the artificial kidney, and ultrasound were all researched here. That innovation will continue at Medicon Village, Ideon Science Park and two world-leading science institutions, Max IV and ESS, put Lund on the international map.
